FDA Investigator: Wei Wang
- Wei Wang first started conducting FDA inspections in 2017, with the last inspection in 2023. Over that time, Wei Wang has conducted 10 inspections at 10 companies across 10 sites.
Documents
FDA 483 Charles River Laboratories Inc, Memphis | 2023
Out-of-stock
Wei Wang
Biologics Form 483
FDA 483 Krystal Biotech, Inc., Pittsburgh | 2022
Out-of-stock
Wei Wang
Biologics Form 483
FDA 483 AveXis, Libertyville | 2019
Out-of-stock
Wei Wang
Biologic Form 483
FDA 483 Symbiosis Pharmaceutical Services Limited, Stirling | 2018
Out-of-stock
Wei Wang
Biologic Form 483
FDA 483 SAFC Carlsbad Inc., Carlsbad | 2017
Out-of-stock
Wei Wang
Biologic Form 483
FDA 483 KITE PHARMA INC, El Segundo | 2017
Out-of-stock
Wei Wang
Biologic Form 483
FDA 483 Grifols Therapeutics Inc., Clayton | 2017
Out-of-stock
Wei Wang
Biologic Form 483
Co-Investigators (24)
- Prajakta A. Varadkar, FDA Investigator
- Zhaohui Ye, FDA Investigator
- Donald B. Ertel, FDA Investigator
- Hoda N. Abadeer, FDA Investigator
- Jessica Chery
- Carl A. Perez, FDA Investigator
- Anna R. Kwilas, FDA Investigator
- Priscilla M. Pastrana, FDA Investigator
- Bo Liang, FDA Investigator
- Jianyang Wang, FDA Investigator
- Eileen A. Liu, FDA Investigator
- Xiuju Lu, FDA Investigator
- Christian Lynch, FDA Investigator
- Jakob Reiser, FDA Investigator
- Burnell M. Henry, FDA Investigator
- Andrew P. Byrnes, FDA Investigator
- Deborah M. Trout, FDA Investigator
- Angela S. Whatley, FDA Investigator
- Christine Harman, FDA Investigator
- Arie Menachem, FDA Investigator
- Michael B. Havert, FDA Investigator
- Graeme E. Price, FDA Investigator
- Bradley J. Dworak, FDA Investigator
- Richard H. Coats, FDA Investigator